EDAP TMS SA (EDAP)
-NasdaqGM 3.68 
0.02(0.59%) 1:04PM EDT - Nasdaq Real Time Price
| Prev Close: | 3.70 |
|---|
| Open: | 3.61 |
|---|
| Bid: | 3.75 x 500 |
|---|
| Ask: | 3.76 x 700 |
|---|
| 1y Target Est: | 6.00 |
|---|
| Beta: | 1.76 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 3.51 - 3.89 |
|---|
| 52wk Range: | 1.43 - 4.94 |
|---|
| Volume: | 45,427 |
|---|
| Avg Vol (3m): | 234,592 |
|---|
| Market Cap: | 69.11M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.63 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- EDAP to Raise $12 Million in Registered Direct OfferingGlobeNewswire(Tue, May 21)
- EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year StudyGlobeNewswire(Mon, May 20)
- Edap TMS CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 16)
- EDAP Reports 23% Increase in First Quarter 2013 RevenuesGlobeNewswire(Thu, May 16)
- Q1 2013 Edap TMS Earnings Release - Before Market OpenCCBN(Thu, May 16)
- EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual MeetingGlobeNewswire(Tue, May 14)
- EDAP Schedules Webcast and Conference Call for First Quarter 2013 ResultsGlobeNewswire(Mon, May 13)
- EDAP Outlines Significant Participation at 2013 American Urological Association Annual MeetingGlobeNewswire(Wed, May 1)
- 5 Health Care Stocks Under $10 to Watchat TheStreet(Tue, Apr 30)
- EDAP Announces 23% First Quarter 2013 Revenue GrowthGlobeNewswire(Thu, Apr 11)
- EDAP TMS SA FinancialsEDGAR Online Financials(Sat, Apr 6)
- Q4 2012 Edap TMS Earnings Release - Before Market OpenCCBN(Tue, Apr 2)
- EDAP Reports Fourth Quarter 2012 and Full Year ResultsGlobeNewswire(Tue, Apr 2)
- EDAP receives FDA filing acceptance of pre-market approval applicationat theflyonthewall.com(Thu, Mar 28)
- EDAP Receives U.S. FDA Filing Acceptance of Pre-Market Approval ApplicationGlobeNewswire(Thu, Mar 28)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.98 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.45 |
|---|
| Quarterly EPS Est
(Mar-13)
: | -0.05 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | -2.79 |
|---|
Business Summary
EDAP TMS S.A., through its subsidiaries, engages in the development, production, marketing, distribution, and maintenance of minimally invasive medical devices for the treatment of urological diseases.
View More